Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | C | RY |
|---|---|---|
| Price | $132.49 | $199.34 |
| Change today | ▲ 0.42% | ▼ 0.06% |
| Market cap | $222.24B | $275.97B |
| Return, 3 months | -7.3% | -0.8% |
| Return, year to date | +15.3% | +19.3% |
| Return, 1 year | +33.1% | +39.1% |
| P/E (TTM) | 14.3 | 17.7 |
| P/B | 1.2 | 2.9 |
| P/E percentile vs own 5y | 69th | 95th |
| Dividend yield | 1.81% | 2.36% |
| Revenue growth (YoY, latest qtr) | +14.3% | +9.1% |
| Net profit growth (YoY) | +49.4% | +11.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 18.0% | 31.2% |
| Return on equity | 8.5% | 17.2% |
| Analyst target vs. price | +19.0% | +12.2% |
| Analyst buy share | 79% | 71% |
| RSI (14) | 46 | 43 |
| 30-day volatility | 22.5% | 17.1% |
| Max drawdown, 1 year | -14.8% | -10.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.